Drug Type CAR-NK |
Synonyms- |
Target |
Action agonists, inhibitors |
Mechanism CD16a agonists(Low affinity immunoglobulin gamma Fc region receptor III-A agonists), CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), IL-15 replacements(Interleukin-15 replacements) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
B-Cell Malignant Neoplasm | Preclinical | United States | 29 Nov 2018 |